Trump anuncia acordo com China em meio a tensões comerciais e negocia com Índia

US attempting to manage simultaneous trade negotiations with China and India, leveraging tariff threats to extract concessions. China accepting 10% reciprocal tariffs while US maintains 30% on Chinese goods (including 20% fentanil surcharge), suggesting asymmetric negotiating outcomes. India positioned as alternative economic partner, reflecting US strategy to diversify Asian engagement beyond China.

Similar to Nixon's 1971 opening to China—using trade negotiations to reshape geopolitical alignments and create strategic alternatives to existing power structures.

Mixed effects: Short-term tariff reductions (10% on Chinese goods) may lower consumer prices on imported goods, but US maintains 30% tariff on Chinese products, keeping prices elevated. Uncertainty around India negotiations and broader reciprocal tariffs creates pricing volatility for consumers dependent on imported goods.

Indicates shift toward bilateral trade negotiations over multilateral frameworks. 90-day tariff reduction period suggests temporary measures pending deeper negotiations. Fentanil-related tariffs remain, signaling continued focus on pharmaceutical supply chain security. Potential for similar agreements with other countries (India) suggests broader tariff restructuring policy.